Myeloproliferative neoplasms in five multiple sclerosis patients

Leukemia Research Reports

Volumn 2, Issue 2, 2013, Pages 61-63

  Thorsteinsdottir, Sigrun ^a   Bjerrum, Ole Weis ^a   Hasselbalch, Hans Carl ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Essential thrombocythemia; Interferon; Multiple sclerosis; Myelofibrosis; Polycythemia vera

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; HEMOGLOBIN; JANUS KINASE 2;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BONE MARROW BIOPSY; CHRONIC INFLAMMATION; CLINICAL ARTICLE; DENMARK; DISEASE ASSOCIATION; FEMALE; GAIN OF FUNCTION MUTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPOIESIS; MYELOPROLIFERATIVE NEOPLASM; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

EID: 84887904264     PISSN: 22130489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lrr.2013.06.004     Document Type: Article

References (10)

1. Tefferi A., Vardiman J.W. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008, 22(1):14-22.
2. Anderson L.A., et al. Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms. American Journal of Hematology 2012, 87(2):175-182.
3. Polman C.H., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology 2011, 69(2):292-302.
4. Koch-Henriksen N., Bronnum-Hansen H., Hyllested K. Incidence of multiple sclerosis in Denmark 1948-1982: a descriptive nationwide study. Neuroepidemiology 1992, 11(1):1-10.
5. Tsiara S.N., et al. A patient with essential thrombocytosis and multiple sclerosis. European Journal of Internal Medicine 2000, 11(6):345-347.
6. Kristinsson S.Y., et al. Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 2010, 95(7):1216-1220.
7. Hasselbalch H.C. Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?. Leukemia Research 2013, 37(2):214-220.
8. Compston A., Coles A. Multiple sclerosis. Lancet 2002, 359(9313):1221-1231.
9. Nexo B.A., et al. The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1. PLoS One 2011, 6(2):e16652.
10. Christensen S., et al. Multiple sclerosis and risk of venous thromboembolism: a population-based cohort study. Neuroepidemiology 2012, 38(2):76-83.